Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT07403188

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

Sponsor: Kyverna Therapeutics

View on ClinicalTrials.gov

Summary

The purpose of this long-term follow-up (LTFU) study is to collect delayed adverse events (AEs) and understand the persistence of KYV-101 (autologous CAR T cell product; gene-modified product), in participants who have been administered KYV-101 (gene-modified product; autologous CAR T cell product). This LTFU protocol will be open to any participant who received at least one infusion of KYV-101 in a previous Kyverna sponsored clinical trial or Investigator Initiated Trial (IIT).

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

Start Date

2025-11-24

Completion Date

2041-01

Last Updated

2026-02-11

Healthy Volunteers

Conditions

Refractory Lupus Nephritis Myasthaenia Gravis Stiff Person Syndrome Rheumatoid Arthritis (RA)Multiple Sclerosis Dermatomyositis Systemic Sclerosis (SSc)

Interventions

DRUG

KYV-101

Autologous fully-human anti-CD19 chimeric antigen receptor T-cell (CD19 CAR T) product.

Locations (1)

University of Colorado, Denver

Denver, Colorado, United States